Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant IV paclitaxel plus trans-uterine arterial cisplatin chemoembolization for locally advanced cervical cancer
ChiCTR2000033920Phase 2Not yet recruiting
- Sponsor
- International Peace Maternity and Child Health Hospital
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel and cisplatin in Cervical Cancer (CC), sponsored by International Peace Maternity and Child Health Hospital. Primary endpoints: Clinical response rate and Pathological response rate. Planned start Jun 2020; status: not yet recruiting.
02
Drugs
paclitaxelcisplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on ChiCTR2000033920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033920.